Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: A population-based cohort study

Annals of Internal Medicine

Volumn 161, Issue 4, 2014, Pages 242-248

  Hwang, Y Joseph ^a   Dixon, Stephanie N ^a   Reiss, Jeffrey P ^a   Wald, Ron ^b   Parikh, Chirag R ^c   Gandhi, Sonja ^a   Shariff, Salimah Z ^a   Pannu, Neesh ^d   Nash, Danielle M ^a   Rehman, Faisal ^a   Garg, Amit X ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CREATININE; OLANZAPINE; QUETIAPINE; RISPERIDONE; BENZODIAZEPINE DERIVATIVE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; AGED; ARTICLE; CANADA; COHORT ANALYSIS; CREATININE BLOOD LEVEL; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MORTALITY; NEUROLEPTIC MALIGNANT SYNDROME; OUTCOME ASSESSMENT; OUTPATIENT; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHABDOMYOLYSIS; RISK FACTOR; SIDE EFFECT; URINE RETENTION; ACUTE KIDNEY INJURY; AGE; BLOOD; CAUSE OF DEATH; CHEMICALLY INDUCED; FEMALE; MALE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CAUSE OF DEATH; CREATININE; DIBENZOTHIAZEPINES; FEMALE; HOSPITALIZATION; HUMANS; HYPOTENSION; MALE; ONTARIO; RETROSPECTIVE STUDIES; RISK FACTORS; RISPERIDONE; URINARY RETENTION;

EID: 84907379550     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-2796     Document Type: Article

References (38)

1. U.S. Food and Drug Administration. Public health advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. Silver Spring, MD: U.S. Food and Drug Administration; 2005. Accessed at www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm053171. htm on 25 April 2013.
2. Health Canada. Increased mortality associated with the use of atypical antipsychotic drugs in elderly patients with dementia. Ottawa, Ontario, Canada: Health Canada; 2005. Accessed at www.healthycanadians.gc.ca/recall-alert-rappel- avis/hc-sc/2005/14307a-eng.php on 25 April 2013.
3. Finkel S. Pharmacology of antipsychotics in the elderly: a focus on atypicals. J Am Geriatr Soc. 2004;52:S258-65. [PMID: 15541166]
4. Cohen R, Wilkins KM, Ostroff R, Tampi RR. Olanzapine and acute urinary retention in two geriatric patients. Am J Geriatr Pharmacother. 2007;5:241-6. [PMID: 17996664]
5. Raitasuo V, Vataja R, Elomaa E. Risperidone-induced neuroleptic malignant syndrome in young patient [Letter]. Lancet. 1994;344:1705. [PMID: 7527886]
6. Ahuja N, Palanichamy N, Mackin P, Lloyd A. Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature. J Psychopharmacol. 2010;24:125-30. [PMID: 18801826] doi: 10.1177/0269881108096901
7. Duggal HS, Singh I. Neuroleptic malignant syndrome presenting with acute renal failure [Letter]. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32: 1074-5. [PMID: 18281139] doi:10.1016/j.pnpbp.2008.01.010
8. Khan I, Vasudevan V, Arjomand F, Ali R, Shahzad S. Quetiapine induced fatal neuroleptic malignant syndrome (NMS) and hyperosmolar hyperglycemic nonketotic coma (HHNC). Chest. 2011;140:113A. doi:10.1378/chest.1114380
9. Sajatovic M, Calabrese JR, Mullen J. Quetiapine for the treatment of bipolar mania in older adults. Bipolar Disord. 2008;10:662-71. [PMID: 18837860] doi: 10.1111/j.1399-5618.2008.00614.x
10. Ritchie CW, Chiu E, Harrigan S, MacFarlane S, Mastwyk M, Halliday G, et al. A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration. Int J Geriatr Psychiatry. 2006;21:171-9. [PMID: 16416458]
11. Sokolski KN, Brown BJ, Melden M. Urinary retention following repeated high-dose quetiapine [Letter]. Ann Pharmacother. 2004;38:899-900. [PMID: 15039480]
12. Knol W, van Marum RJ, Jansen PA, Souverein PC, Schobben AF, Egberts AC. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc. 2008;56:661-6. [PMID: 18266664] doi:10.1111/j.1532-5415.2007.01625.x
13. Pariente A, Fourrier-Réglat A, Ducruet T, Farrington P, Béland SG, Dartigues JF, et al. Antipsychotic use and myocardial infarction in older patients with treated dementia. Arch Intern Med. 2012;172:648-53. [PMID: 22450214] doi: 10.1001/archinternmed.2012.28
14. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225-35. [PMID: 19144938] doi:10.1056/NEJMoa0806994
15. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573-7. [PMID: 17938396]
16. Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10:67-71. [PMID: 12879144]
17. Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, et al. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med. 2013;158:869-76. [PMID: 23778904] doi: 10.7326/0003-4819-158-12-201306180-00004
18. Lam NN, Weir MA, Yao Z, Blake PG, Beyea MM, Gomes T, et al. Risk of acute kidney injury from oral acyclovir: a population-based study. Am J Kidney Dis. 2013;61:723-9. [PMID: 23312723] doi:10.1053/j.ajkd.2012.12.008
19. Zhao YY, Weir MA, Manno M, Cordy P, Gomes T, Hackam DG, et al. New fibrate use and acute renal outcomes in elderly adults: a population-based study. Ann Intern Med. 2012;156:560-9. [PMID: 22508733] doi:10.7326/0003-4819- 156-8-201204170-00003
20. Shih AW, Weir MA, Clemens KK, Yao Z, Gomes T, Mamdani MM, et al. Oral bisphosphonate use in the elderly is not associated with acute kidney injury. Kidney Int. 2012;82:903-8. [PMID: 22695327] doi:10.1038/ki.2012.227
21. Gandhi S, Fleet JL, Bailey DG, McArthur E, Wald R, Rehman F, et al. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA. 2013;310:2544-53. [PMID: 24346990] doi:10.1001/jama.2013.282426
22. Weir MA, Beyea MM, Gomes T, Juurlink DN, Mamdani M, Blake PG, et al. Orlistat and acute kidney injury: an analysis of 953 patients [Letter]. Arch Intern Med. 2011;171:703-4. [PMID: 21482850] doi:10.1001 /archinternmed.2011.103
23. Gandhi S, Shariff SZ, Beyea MM, Weir MA, Hands T, Kearns G, et al. Identifying geographical regions serviced by hospitals to assess laboratory-based outcomes. BMJ Open. 2013;3. [PMID: 23293246] doi:10.1136/bmjopen-2012-001921
24. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46: 399-424. [PMID: 21818162]
25. Johns Hopkins ACG System. Baltimore: Johns Hopkins Univ; 2013. Accessed at http://acg.jhsph.org/index.php/the-acg-system-advantage/acgs on 15 January 2014.
26. Reid RJ, MacWilliam L, Verhulst L, Roos N, Atkinson M. Performance of the ACG case-mix system in two Canadian provinces. Med Care. 2001;39:86-99. [PMID: 11176546]
27. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebocontrolled trials. JAMA. 2005;294:1934-43. [PMID: 16234500]
28. Juurlink D, Preyra C, Croxford R, Chong A, Austin P, Tu J, et al. Canadian Institute for Health Information Discharge Abstract Database: a validation study. Toronto, Ontario, Canada: Institute for Clinical Evaluative Sciences; 2006. Accessed at www.ices.on.ca/flip-publication/canadian-istitute- for-health-information-discharge/index.html#41/z on 23 June 2014.
29. Jha P, Deboer D, Sykora K, Naylor CD. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol. 1996;27:1335-42. [PMID: 8626941]
30. Hwang YJ, Shariff SZ, Gandhi S, Wald R, Clark E, Fleet JL, et al. Validity of the International Classification of Diseases, Tenth Revision code for acute kidney injury in elderly patients at presentation to the emergency department and at hospital admission. BMJ Open. 2012;2. [PMID: 23204077] doi:10.1136/bmjopen-2012-001821
31. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2:1-138. Accessed at www.kdigo.org/clinical-practice-guidelines/ pdf/KDIGO%20AKI%20Guideline.pdf on 23 June 2014.
32. Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Siml Comput. 2009;38:1228-34.
33. Ontario's Local Health Integration Networks. Accessed at www.lhins.on.ca/aboutlhin.aspx on 20 April 2014.
34. Fleet JL, Dixon SN, Shariff SZ, Quinn RR, Nash DM, Harel Z, et al. Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol. 2013;14:81. [PMID: 23560464] doi:10.1186/1471-2369-14-81
35. Rabins PV, Lyketsos CG. Antipsychotic drugs in dementia: what should be made of the risks? [Editorial]. JAMA. 2005;294:1963-5. [PMID: 16234504]
36. Hilmer SN, Gnjidic D, Abernethy DR. Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults. J Gerontol A Biol Sci Med Sci. 2012;67:181-8. [PMID: 21653991] doi:10.1093/gerona/glr066
37. Stürmer T, Jonsson Funk M, Poole C, Brookhart MA. Nonexperimental comparative effectiveness research using linked healthcare databases. Epidemiology. 2011;22:298-301. [PMID: 21464649] doi:10.1097/EDE.0b013e318212640c
38. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158:915-20. [PMID: 14585769]